BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noorani L, Pourgholami MH, Liang M, Morris DL, Stenzel M. Albendazole loaded albumin nanoparticles for ovarian cancer therapy. European Journal of Nanomedicine 2014;6. [DOI: 10.1515/ejnm-2014-0026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Panjwani D, Patel S, Mishra D, Patel V, Yadav M, Dharamsi A, Patel A. Avidin-Biotin functionalized self-assembled protein nanoparticles as EGFR targeted therapeutics for the treatment of lung cancer: characterization and cell viability. Journal of Dispersion Science and Technology. [DOI: 10.1080/01932691.2022.2099888] [Reference Citation Analysis]
2 Aziz A, Sefidbakht Y, Rezaei S, Kouchakzadeh H, Uskoković V. Doxorubicin-loaded, pH-sensitive Albumin Nanoparticles for Lung Cancer Cell Targeting. J Pharm Sci 2021:S0022-3549(21)00679-1. [PMID: 34896345 DOI: 10.1016/j.xphs.2021.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Saber S, Nasr M, Saad AS, Mourad AAE, Gobba NA, Shata A, Hafez AM, Elsergany RN, Elagamy HI, El-Ahwany E, Amin NA, Girgis S, Elewa YHA, Mahmoud MH, Batiha GE, El-Rous MA, Kamal I, Kaddah MMY, Khodir AE. Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression. Biomed Pharmacother 2021;142:112029. [PMID: 34416629 DOI: 10.1016/j.biopha.2021.112029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
4 Gregory-bass R, Winfield LL. Preliminary Analysis of Anti-proliferative, Apoptotic, and Anti-migratory Effects llw-3-6 in Skov-3 Ovarian Cystadenocarcinoma Cell Line. LDDD 2020;17:1319-1324. [DOI: 10.2174/1570180817666200129142949] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Maqbool F, Falconer JR, Moyle PM. Supercritical fluid assembly of albendazole liposomes targeting gastrin-releasing peptide receptor overexpressing tumors. Nanomedicine (Lond) 2020. [PMID: 32484025 DOI: 10.2217/nnm-2020-0048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Liang J, Li R, He Y, Ling C, Wang Q, Huang Y, Qin J, Lu W, Wang J. A novel tumor-targeting treatment strategy uses energy restriction via co-delivery of albendazole and nanosilver. Nano Res 2018;11:4507-23. [DOI: 10.1007/s12274-018-2032-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
7 Movahedi F, Li L, Gu W, Xu ZP. Nanoformulations of albendazole as effective anticancer and antiparasite agents. Nanomedicine (Lond) 2017;12:2555-74. [PMID: 28954575 DOI: 10.2217/nnm-2017-0102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
8 Bhushan B, Khanadeev V, Khlebtsov B, Khlebtsov N, Gopinath P. Impact of albumin based approaches in nanomedicine: Imaging, targeting and drug delivery. Adv Colloid Interface Sci 2017;246:13-39. [PMID: 28716187 DOI: 10.1016/j.cis.2017.06.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 69] [Article Influence: 10.2] [Reference Citation Analysis]
9 Chakraborty S, Dhakshinamurthy GS, Misra SK. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications. J Biomed Mater Res A 2017;105:2906-28. [PMID: 28643475 DOI: 10.1002/jbm.a.36141] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]